Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine




Disease c syndrome
Comorbidity |vascular disease
Sentences 78
PubMedID- 21841320 Objective: the aim of this study was to evaluate the effects of health checkup and the health education "hokenshido" program based on the concept that visceral fat accumulation causes metabolic syndrome (mets), leading to cardiovascular disease (cvd).
PubMedID- 24716162 It is also strongly related to other pathological conditions, including obesity, diabetes, cardiovascular diseases, and symptoms of metabolic syndrome.
PubMedID- 26089614 Abdominal obesity (ao) and metabolic syndrome (mets) are associated with the cardiovascular disease and type 2 diabetes.
PubMedID- 21785705 Finally, there is some evidence that support an important role of mineralocorticoid receptor blockers in the treatment of resistant hypertension and in the prevention of cardiovascular diseases in patients with metabolic syndrome and type 2 diabetes mellitus.
PubMedID- 20509277 Aim: to analyze the components of metabolic syndrome from patients with cardiovascular disease (myocardial infarction).
PubMedID- 20940070 Analysis results on population attributable risks showed that about a quarter of total diabetes occurrence and more than 10% of cardiovascular disease was attributable to the metabolic syndrome.
PubMedID- 23961478 For high-risk patients, ldl-c treatment goal was ldl <100 mg/dl but an ldl-c goal of <70 mg/dl was considered a therapeutic option for very high risk patients who had recent heart attacks, cardiovascular disease with diabetes, metabolic syndrome, or severe/poorly controlled risk factors.
PubMedID- 21679922 Microalbuminuria accounts for the increased risk of cardiovascular disease in patients with metabolic syndrome.
PubMedID- 25633268 Aims: matrix metalloproteinases (mmps) and their tissue inhibitors (timps) are dysregulated in metabolic syndrome (mets) and associated with atherosclerosis and cardiovascular disease (cvd).
PubMedID- 21516134 Although several studies have reported that the chemerin/chemr23 axis is strongly associated with cardiovascular disease and aspects of metabolic syndrome11, 26, 27, there was no direct evidence for the role of the chemerin/chemr23 axis in maintaining endothelial function.
PubMedID- 22417140 Recent research has begun to elucidate the effects of hypothalamic inflammation in causing diverse components of metabolic syndrome leading to diabetes and cardiovascular disease.
PubMedID- 20609696 In addition, hypertension is an important contributor to increasing cardiovascular disease risk in patients with the cardiometabolic syndrome.
PubMedID- 24008519 Comment to: diversity of metabolic syndrome criteria in association with cardiovascular diseases--a family medicine-based investigation.
PubMedID- 20671994 On the other hand, no clinical trial evidence indicates that these drugs will reduce risk for cardiovascular disease events in patients with the metabolic syndrome.
PubMedID- 19958158 Background: metabolic syndrome is associated with cardiovascular disease and oxidative stress.
PubMedID- 25247821 These findings have important public health implications due to the known cardiovascular disease risk factors associated with metabolic syndrome.
PubMedID- 20004035 Aims: to compare the cardiovascular disease (cvd) risk associated with the metabolic syndrome (mets) and dysglycemia, independent of each other during a median follow-up of 6.7 years.
PubMedID- 24819036 Changes in concentration and several single-nucleotide polymorphisms (snp) at the gpx3 gene have been associated with vascular diseases, but the relationship of gpx3 with metabolic syndrome (mets) remains unexplored.
PubMedID- 22760893 Os is associated with endothelial dysfunction and metabolic syndrome, which leads to cardiovascular diseases.
PubMedID- 24393433 Objective: metabolic syndrome (mets) is associated with cardiovascular disease (cvd).
PubMedID- 24453423 Importantly also, whereas consistent disparities in the associations of cardiovascular risk factors including crp concentrations, blood pressure, lipid levels, obesity and metabolic syndrome with cardiovascular disease in black compared to white african patients with ra were recently identified by us [27–29], ethnicity did not impact the il-6-endothelial activation relationship in the present investigation.
PubMedID- 19781706 There is ample epidemiological evidence linking obesity, and the related ‘metabolic syndrome’, with vascular disease [1].
PubMedID- 19720470 Insulin resistance (ir), which is a major component of metabolic syndrome (mets), is associated with cardiovascular disease risk.
PubMedID- 23677576 Cancer risk in patients with manifest vascular disease: effects of smoking, obesity, and metabolic syndrome.
PubMedID- 23852333 Diversity of metabolic syndrome criteria in association with cardiovascular diseases--a family medicine-based investigation.
PubMedID- 26525819 Thus, primary and secondary prevention of cerebrovascular disease in patients with metabolic syndrome should include haemangiocorrective, antithrombotic, antioxidant and endothelium-protective treatment, as well as therapy of the main components of metabolic syndrome.
PubMedID- 22916265 The higher risk of cardiovascular disease in patients with metabolic syndrome and hypertension could depend partly on the degree of sympathetic hyperactivity.
PubMedID- 24676221 Background: subclinical cardiovascular disease is prevalent in patients with metabolic syndrome (metsyn).

Page: 1 2